Drug Manufacturers - Specialty & Generic | Healthcare
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.
Market Cap
27588696064
Current Price
93.99
52 Week Range
57.5 - 107.54
Previous Close
89.8
Open
90.0
Sector
Healthcare
Address
85, Industrial Area 'A', , Ludhiana, 141003, India
Phone
+91-16122-25531
Website
https://www.iolcp.com
Day Low
90.0
Day High
95.35
Dividend Yield
0.9
PE Ratio
27.00862
Earnings Per Share
3.48
Beta
0.571
EBITDA
2023000064
Book Value
57.473
EPS
4.6
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Pardeep Kumar Khanna | Chief Financial Officer | 54 | 1970 |
Mr. Abhay Raj Singh | VP, Company Secretary & Compliance Officer | - | - |
Mr. Varinder Gupta | MD & Whole Time Director | 62 | 1962 |
Mr. Vikas Gupta | Joint Managing Director & Executive Director | 32 | 1992 |
Mr. Kushal Kumar Rana | Director of Works & Wholetime Director | 55 | 1969 |
Mr. Abhiraj Gupta | Executive Director | - | - |
Dr. Gurupur Ganesh Pai | Chief Technology Officer | 72 | 1952 |
Mr. Damandeep Singh | President of Project | 50 | 1974 |
Mr. Kamlesh Jayantilal Ranbhan | President of R&D | 59 | 1965 |
Mr. Gopal Singla | President of Engineering | 48 | 1976 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.